Cleveland Woman Becomes First Breast Cancer Vaccine Recipient

An American woman from Florida became the first person to receive a breast cancer vaccine.

The patient's experience with the deadly disease was not an easy journey. She underwent many chemotherapy sessions while battling triple-negative breast cancer in 2018.

Florida Woman's Struggle in Fighting Breast Cancer

One of the most common kinds of cancer which affect many women around the world is breast cancer. While some people can avoid having it, some can't dodge it due to genetics. Jennifer "Jenni" Davis' fight against breast cancer is a rollercoaster ride. She did not only combat a deadly disease but the deadliest form of it, which is triple-negative breast cancer, according to News 5 Cleveland.

Although this type of breast cancer is quite rare since it only accounts for 10 to 15% of breast cancer cases, it's known to be the worst of its kind. The American Cancer Society says that only a few treatment options are available to address this breast cancer, and most often, it's a more aggressive form to deal with. Davis, who is a Florida resident, said that aside from chemotherapy, she underwent breast reconstruction, a double mastectomy, and 26 rounds of radiation.

She feared that her body could cave in at any time, given the medication and radiation she had been receiving.

"With triple-negative, when you're done with treatment, that's kind of it. There's nothing that I take long-term. There's no pill. There's nothing I take to make sure it won't come back," Davis said in an interview with Fox35 Orlando.

How Davis Participated in Breast Cancer Vaccine Trial

Jennifer, a mother of three, has discovered that the Department of Defense at the Cleveland Medical Clinic is planning to stage trials for patients with breast cancer.

She volunteered to participate in the test after learning that the study would involve an experimental vaccine for the said disease.

According to Daily Caller, the participants were told to take three doses of the breast cancer vaccine which will last for two weeks. The healthcare professionals will monitor if there are side effects or other body responses to the patients.

Thankfully, Jen passed the trial and became the first patient to receive a special vaccine for the deadly breast cancer form, according to Dr. Mega Kruse, a breast medical oncologist at Cleveland Clinic.

To this day, Jennifer reports that she does not feel any serious complications after administering the vaccine. What's better is that she's now cancer-free.

Davis believes that one day, women will have no reason to worry as they can now prevent triple-negative breast cancer from developing.

Jennifer assures that she will comply with the follow-up check-ups as part of the clinical trial.